Finding Mutations Without Sequencing

Courtesy of TrimGenIf you are not lucky enough to have a restriction enzyme site in your mutation-of-interest, chances are you have had to fall back on sequencing to detect it. But this time-consuming method of detecting mutations could soon be a thing of the past, thanks to new technology called Mutector from Sparks, Md.-based TrimGen http://www.trimgen.com.According to marketing manager Brad Oswald, Mutector eliminates false positives and negatives and produces results in 2–3 hours, comp

Written byHelen Dell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Courtesy of TrimGen

If you are not lucky enough to have a restriction enzyme site in your mutation-of-interest, chances are you have had to fall back on sequencing to detect it. But this time-consuming method of detecting mutations could soon be a thing of the past, thanks to new technology called Mutector from Sparks, Md.-based TrimGen http://www.trimgen.com.

According to marketing manager Brad Oswald, Mutector eliminates false positives and negatives and produces results in 2–3 hours, compared with the 6–8 hours required for sequencing. And at around $4 per test, it is less expensive than sending DNA out to a sequencing facility.

"We really like the technology," says David Sidransky, director of head and neck cancer research at Johns Hopkins University; he has been using Mutector to detect BRAF gene mutations in biopsy specimens of suspected thyroid tumors. "This technique is not only accurate, it is also quick, efficient, and cheaper ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies